Bussmann W D, Giebeler B
Klin Wochenschr. 1983 Apr 15;61(8):423-8. doi: 10.1007/BF01488157.
The daily dose of nitrates was determined in 293 patients who had undergone coronary angiography seven years earlier. A questionnaire was filled out by those still living; medical records and information provided by family physicians were used for those who had died during the intervening period. The dose could be ascertained in a total of 168 patients. Patients were divided into two groups: in group I were those with a daily isosorbide dinitrate dose of less than 40 mg (n = 46), in group II those with a dose greater than 40 mg (n = 72). 56 patients had died. Two-thirds of them had been on the low-dose regimen, whereas only one-third were in the high-dose group. The extent of ventricular impairment was comparable in both groups. Seven-year mortality in group I was 39% with a mean daily nitrate dose of 14 mg. In group II, however, only 26% died with a mean daily dose of 55 mg. The difference can already be seen during the first year. Age, extent of coronary sclerosis, degree of ventricular damage, and cardiac size were identical in both groups. Thus mortality rate in group II was reduced by 30-40%. A causal relation to the height of the nitrate dose should be considered.
对7年前接受过冠状动脉造影的293名患者的硝酸盐日剂量进行了测定。在世的患者填写了一份问卷;对于在此期间死亡的患者,则使用家庭医生提供的病历和信息。总共可以确定168名患者的剂量。患者被分为两组:第一组是每日二硝酸异山梨酯剂量低于40毫克的患者(n = 46),第二组是剂量大于40毫克的患者(n = 72)。56名患者已经死亡。其中三分之二接受低剂量治疗,而只有三分之一在高剂量组。两组的心室损害程度相当。第一组的7年死亡率为39%,平均每日硝酸盐剂量为14毫克。然而,在第二组中,平均每日剂量为55毫克的情况下,只有26%的患者死亡。这种差异在第一年就已经可以看出。两组患者在年龄、冠状动脉硬化程度、心室损伤程度和心脏大小方面相同。因此,第二组的死亡率降低了30% - 40%。应考虑与硝酸盐剂量高低的因果关系。